Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in rats

Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant... Psychopharmacology (2017) 234:2597–2605 DOI 10.1007/s00213-017-4652-3 ORIGINAL INVESTIGATION Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in rats 1,2 3 4 5 E. Andrew Townsend & Jennifer E. Naylor & S. Stevens Negus & Shelley R. Edwards & 5 6 7,8 Hina N. Qureshi & Hunter W. McLendon & Christopher R. McCurdy & 7 9 9 9 Coco N. Kapanda & Jussara M. do Carmo & Fernanda S. da Silva & John E. Hall & 10 2 Kenneth J. Sufka & Kevin B. Freeman Received: 18 April 2017 /Accepted: 19 May 2017 /Published online: 31 May 2017 Springer-Verlag Berlin Heidelberg 2017 Abstract effect functions were each determined for oxycodone, Rationale Strategies to reduce the misuse of mu opioid ago- nalfurafine, and the same oxycodone/nalfurafine mixture pro- nists are critically needed. Previous work has shown that kap- portions. Finally, the respiratory-depressant effects of equi- pa opioid agonists can diminish the abuse-related effects and antinociceptive doses of oxycodone, nalfurafine, and the mix- augment the antinociceptive effects of mu agonists. However, tures were compared. use of traditional kappa agonists is limited by their dysphoric Results Nalfurafine decreased the reinforcing effects of oxy- side http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Psychopharmacology Springer Journals

Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in rats

9 pages
Read Article

Loading next page...
 
/lp/springer_journal/effects-of-nalfurafine-on-the-reinforcing-thermal-antinociceptive-and-F1d6PeGeko
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag Berlin Heidelberg
Subject
Biomedicine; Neurosciences; Pharmacology/Toxicology; Psychiatry
ISSN
0033-3158
eISSN
1432-2072
D.O.I.
10.1007/s00213-017-4652-3
Publisher site
See Article on Publisher Site

Abstract

Psychopharmacology (2017) 234:2597–2605 DOI 10.1007/s00213-017-4652-3 ORIGINAL INVESTIGATION Effects of nalfurafine on the reinforcing, thermal antinociceptive, and respiratory-depressant effects of oxycodone: modeling an abuse-deterrent opioid analgesic in rats 1,2 3 4 5 E. Andrew Townsend & Jennifer E. Naylor & S. Stevens Negus & Shelley R. Edwards & 5 6 7,8 Hina N. Qureshi & Hunter W. McLendon & Christopher R. McCurdy & 7 9 9 9 Coco N. Kapanda & Jussara M. do Carmo & Fernanda S. da Silva & John E. Hall & 10 2 Kenneth J. Sufka & Kevin B. Freeman Received: 18 April 2017 /Accepted: 19 May 2017 /Published online: 31 May 2017 Springer-Verlag Berlin Heidelberg 2017 Abstract effect functions were each determined for oxycodone, Rationale Strategies to reduce the misuse of mu opioid ago- nalfurafine, and the same oxycodone/nalfurafine mixture pro- nists are critically needed. Previous work has shown that kap- portions. Finally, the respiratory-depressant effects of equi- pa opioid agonists can diminish the abuse-related effects and antinociceptive doses of oxycodone, nalfurafine, and the mix- augment the antinociceptive effects of mu agonists. However, tures were compared. use of traditional kappa agonists is limited by their dysphoric Results Nalfurafine decreased the reinforcing effects of oxy- side

Journal

Psychopharmacology – Springer Journals

Published: May 31, 2017

References

  • Low efficacy opioids: implications for sex differences in opioid antinociception
    Barrett, AC
  • Activation of the brain melanocortin system is required for leptin-induced modulation of chemorespiratory function
    Bassi, M; Nakamura, NB; Furuya, WI; Colombari, DS; Menani, JV; Carmo, JM; Silva, AA; Hall, JE; Colombari, E
  • Effects of the kappa-opioid receptor agonist U-50,488 on morphine-induced place preference conditioning in the developing rat
    Bolanos, CA; Garmsen, GM; Clair, MA; McDougall, SA
  • Kappa-opioid receptor signaling and brain reward function
    Bruijnzeel, AW
  • Biased agonism at kappa opioid receptors: implication in pain and mood disorders
    Dogra, S; Yadav, PN
  • Adverse effects of opioid analgesic drugs
    Duthie, DJ; Nimmo, WS
  • Assessment of the kappa opioid agonist, salvinorin a, as a punisher of drug self-administration in monkeys
    Freeman, KB; Naylor, JE; Prisinzano, TE; Woolverton, WL
  • Blockade of morphine reward through the activation of kappa-opioid receptors in mice
    Funada, M; Suzuki, T; Narita, M; Misawa, M; Nagase, H
  • Kappa opioid inhibition of morphine and cocaine self-administration in rats
    Glick, SD; Maisonneuve, IM; Raucci, AS
  • Possible pharmacotherapy of the opioid kappa receptor agonist for drug dependence
    Hasabe, K; Kawai, K; Suzuki, T; Kawamura, K; Tanaka, T; Narita, M
  • Simultaneous determination of circadian rhythms of locomotor activity and body temperature in the rat
    Honma, K; Hiroshige, T
  • Self-administration and behavioral economics of second-generation synthetic cathinones in male rats
    Huskinson, SL; Naylor, JE; Townsend, EA; Rowlett, JK; Blough, BE; Freeman, KB
  • Nalfurafine hydrochloride to treat pruritus: a review
    Inui, S
  • The emerging therapeutic roles of kappa-opioid agonists
    Jones, MR; Kaye, AD; Kaye, AJ; Urman, RD
  • Effects of atypical kappa-opioid receptor agonists on intrathecal morphine-induced itch and analgesia in primates
    Ko, MC; Husbands, SM
  • Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: a phase III, randomized, double-blind, placebo-controlled study
    Kumagai, H; Ebata, T; Takamori, K; Muramatsu, T; Nakamoto, H; Suzuki, H
  • Efficacy and safety of a novel ĸ-agonist for managing intractable pruritus in dialysis patients
    Kumagai, H; Ebata, T; Takamori, K; Miyasato, K; Muramatsu, T; Nakamoto, H
  • Kappa-opioid receptor agonist U50,488H modulates cocaine and morphine self-administration in drug naïve rats and mice
    Kuzmin, AV; Semenova, S; Gerrits, MA; Zvartau, EE; Van Ree, JM
  • Ventilation measured by body plethysmography in hibernating mammals and in poikitotherms
    Milan, A
  • Kappa-opioid receptors and analgesia
    Millan, MJ
  • Effects of a newly synthesized kappa opioid receptor agonist, TRK-820, on the discriminative stimulus and rewarding effects of cocaine in rats
    Mori, T; Nomura, M; Nagase, H; Narita, M; Suzuki, T
  • Preclinical assessment of candidate analgesic drugs: recent advancements and future challenges
    Negus, SS; Vanderah, TW; Brandt, MR; Bilsky, EJ; Becerra, L; Borsook, D
  • Mu/kappa opioid interactions in rhesus monkeys: implications for analgesia and abuse liability
    Negus, SS; Schrode, K; Stevenson, GW
  • Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor
    Schattaurer, SS; Kuhar, JR; Song, A; Chavkin, C
  • Differential roles of opioid receptors in respiration, respiratory disease, and opiate-induced respiratory depression
    Shook, JE; Watkins, WD; Camporesi, EM
  • Drug synergism and dose-effect data analysis
    Tallarida, RJ
  • Revisiting the isobole and related quantitative methods for assessing drug synergism
    Tallarida, RJ
  • Reduced cocaine self-administration in muscarinic M5 acetylcholine receptor-deficient mice
    Thomsen, M; Woldbye, D; Wortwein, G; Fink-Jensen, A; Wess, J; Caine, SB
  • Corn oil, but not cocaine, is a more effective reinforcer in obese than in lean Zucker rats
    Townsend, EA; Beloate, LN; Huskinson, SL; Roma, PG; Freeman, KB
  • One year long-term study on the abuse-liability of nalfurafine in hemodialysis patients
    Ueno, Y; Mori, A; Yanagita, T

You’re reading a free preview. Subscribe to read the entire article.

Try 2 weeks free now

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

or browse the journals available

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off

Sign up
for free
Start 14 day
Free Trial